Af­ter 'mis­lead­ing' in­for­ma­tion de­lays FDA in­spec­tion, Chi­nese API man­u­fac­tur­er hit with an OAI

Chi­nese API man­u­fac­tur­er Sichuan Dee­bio Phar­ma­ceu­ti­cal re­ceived an “of­fi­cial ac­tion in­di­cat­ed” clas­si­fi­ca­tion fol­low­ing a Sep­tem­ber Form 483 de­tail­ing qual­i­ty con­trol and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.